Pharmabiz

Takeda announces first and only UC treat-to-target trial shows treating to disease clearance vs. symptomatic remission with Entyvio prolongs time to first disease-related ...

Takeda announces first and only UC treat-to-target trial shows treating to disease clearance vs. symptomatic remission with Entyvio prolongs time to first disease-related complica ...
Pharmabiz

IIT Madras launches finishing school to develop industry-ready biotechnology professionals

IIT Madras launches finishing school to develop industry-ready biotechnology professionals: Our Bureau, Mumbai Wednesday, October 21, 2026, 17:40 Hrs [IST] Indian Institute of Tec ...
Pharmabiz

Clene seeks US FDA approval for CNM-Au8 for the treatment of amyotrophic lateral sclerosis

Clene seeks US FDA approval for CNM-Au8 for the treatment of amyotrophic lateral sclerosis: Salt Lake City Wednesday, October 21, 2026, 17:00 Hrs [IST] Clene Inc., a clinical-stag ...
Pharmabiz

Sanofi gets CDSCO approval for Qfitlia in India

The Central Drugs Standard Control Organization (CDSCO), under the Drug Controller General of India (DCGI), has granted Marketing Authorization to Qfitlia (Fitusiran), the first antithrombin-lowering ...
Pharmabiz

Bharat Biotech’s Nucelion & VeGen Bio to build end-to-end pathway for cell therapy innovation

Bharat Biotech’s Nucelion & VeGen Bio to build end-to-end pathway for cell therapy innovation: Our Bureau, Bengaluru Wednesday, October 21, 2026, 16:10 Hrs [IST] Nucelion Therap ...
Pharmabiz

Insmed introduces Brinsupri tablets 25 mg to treat non-cystic fibrosis bronchiectasis in Japan

Insmed introduces Brinsupri tablets 25 mg to treat non-cystic fibrosis bronchiectasis in Japan: Bridgewater, New Jersey Wednesday, October 21, 2026, 16:00 Hrs [IST] Insmed Incorpo ...
Pharmabiz

Motorica launches local production of its own bionic prostheses in India

Motorica launches local production of its own bionic prostheses in India: Our Bureau, Bengaluru Wednesday, October 21, 2026, 15:50 Hrs [IST] Motorica Group, a leading Russian MedT ...
Pharmabiz

Roche to present pivotal data at ESMO 2026, showcasing advances across its lung and breast cancer late-stage portfolio

Roche to present pivotal data at ESMO 2026, showcasing advances across its lung and breast cancer late-stage portfolio: Basel Wednesday, October 21, 2026, 15:00 Hrs [IST] Roche wi ...
Pharmabiz

Enable Injections announces approval in Japan for CirCLIQ Injector based on enFuse On-Body Delivery System

Enable Injections announces approval in Japan for CirCLIQ Injector based on enFuse On-Body Delivery System: Cincinnati Wednesday, October 21, 2026, 14:00 Hrs [IST] Enable Injectio ...
Pharmabiz

Dr. Reddy’s receives DCGI Approval for Zytorvi

Dr. Reddy’s Laboratories Ltd. announced that the Central Drugs Standard Control Organisation (CDSCO), under the Drugs Controller General of India (DCGI), has approved Zytorvi (toripalimab) in ...
Pharmabiz

Sun Pharma receives NCCN Category 2A Preferred designation for Unloxcyt in advanced CSCC

Sun Pharma receives NCCN Category 2A Preferred designation for Unloxcyt in advanced CSCC: Our Bureau, Mumbai Wednesday, October 21, 2026, 13:15 Hrs [IST] Sun Pharmaceutical Indust ...
Pharmabiz

GSK presents first global data for Ris-Rez in extensive-stage small cell lung cancer

GSK presents first global data for Ris-Rez in extensive-stage small cell lung cancer: London, UK Wednesday, October 21, 2026, 13:00 Hrs [IST] GSK plc announced the first global da ...